Horizon Therapeutics Public Limited (NASDAQ: HZNP) Receives Hold Rating from Analysts while Continuing to Address Critical Medical Needs
Horizon Therapeutics Public Limited (NASDAQ: HZNP) has received a "Hold" rating from eight brokerages currently covering the company, according to ...